ReviewCell death discovery2025
Unraveling the mechanisms of LncRNAs in cervical cancer: a comprehensive review.
Review in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- LncRNA DNM3OS suppresses proliferation, invasion, and epithelial-mesenchymal transition in cervical cancer cells via miR-454-3p.Molecular biology reports · 2026Article
- Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cervical cancer (CC) ranks as the fourth most prevalent malignancy and the second leading cause of cancer-related mortality in women. Central to its pathology are long non-coding RNAs (LncRNAs), a class of transcripts exceeding 200 nucleotides that do not encode proteins. Instead, they function as critical regulators of gene transcription, chromatin remodeling, and cell cycle progression by interacting with DNA, RNA, or proteins, thereby influencing a range of physiological and pathological processes. As research on LncRNA function deepens, its critical role in tumor biology has become increasingly apparent. LncRNAs have attracted considerable attention in recent years regarding their role in the development and progression of CC. LncRNAs are involved in the proliferation, migration, and invasion of CC cells, and also regulate multiple signaling pathways by interacting with other molecules to influence tumor progression. Although several LncRNAs have been identified as biomarkers of CC, and research on their potential as therapeutic targets is advancing, their specific mechanisms of action and clinical application remain poorly understood. This review aims to comprehensively analyze the biological functions and mechanisms of LncRNAs in CC and explore their clinical application potential, providing new insights and directions for the early diagnosis and treatment of CC.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.